Research Progress of Exosomal miRNA in Hepatocellular Carcinoma

Tianhong ZHANG; Hongju YANG

doi:10.12259/j.issn.2095-610X.S20220221

Volume 43 Issue 2

Mar. 2022

Turn off MathJax

Article Contents

Article Navigation > Journal of Kunming Medical University > 2022 > 43(2): 150-153

Tianhong ZHANG, Hongju YANG. Research Progress of Exosomal miRNA in Hepatocellular Carcinoma[J]. Journal of Kunming Medical University, 2022, 43(2): 150-153. doi: 10.12259/j.issn.2095-610X.S20220221

Citation:

Tianhong ZHANG, Hongju YANG. Research Progress of Exosomal miRNA in Hepatocellular Carcinoma[J]. Journal of Kunming Medical University, 2022, 43(2): 150-153. doi: 10.12259/j.issn.2095-610X.S20220221

Tianhong ZHANG, Hongju YANG. Research Progress of Exosomal miRNA in Hepatocellular Carcinoma[J]. Journal of Kunming Medical University, 2022, 43(2): 150-153. doi: 10.12259/j.issn.2095-610X.S20220221

Citation:

PDF( 508 KB)

Research Progress of Exosomal miRNA in Hepatocellular Carcinoma

doi: 10.12259/j.issn.2095-610X.S20220221

Tianhong ZHANG^{1, 2},
Hongju YANG^{1, 2
,
,}

1.
Dept. of Rehabilitation Medicine，Yunnan Health Rehabilitation Center，Yunnan 650307
2.
Dept. of Geriatric Gastroenterology，The First Affiliated Hospital of Kunming Medical University，Kunming Yunnan 650000，China

Received Date: 2021-12-13
Available Online: 2022-02-24
Publish Date: 2022-03-04

Abstract

Abstract

Exosomes are vesicle bodies secreted by different cells, which promote the occurrence and development of liver cancer through various mechanisms.At present, studies on the role of exosomal miRNA in liver cancer have aroused wide attention.According to the characteristics of exosomal miRNA, the pathogenesis of liver cancer can be better understood, which is of great significance for the diagnosis and treatment of liver cancer.In this paper, the research progress of exosomal miRNA in the development of hepatocellular carcinoma is reviewed.
- Hepatocellular carcinoma,
- Exosomes,
- miRNA

FullText(HTML)

References(35)

References

[1]	Bray F,Ferlay J,Soerjomataram I,et al. Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer Journal for Clinicians,2018,68(6):394-424. doi: 10.3322/caac.21492
[2]	Navin P J,Venkatesh S K. Hepatocellular carcinoma:State of the art imaging and recent advances[J]. Clin Transl Hepatol,2019,7:72-85.
[3]	Sasaki R,Kanda T,Yokosuka O,et al. Exosomes and hepatocellular carcinoma:From bench to bedside[J]. Int J Mol Sci,2019,20(6):1406. doi: 10.3390/ijms20061406
[4]	Tsuchiya A,Ogawa M,Watanabe T,et al. Diverse perspectives to address for the future treatment of heterogeneous hepatocellular carcinoma[J]. Heliyon,2019,5:1325.
[5]	Nojehdehi S,Soudi S,Hesampour A,et al. Immunomodulatory effects of mesenchymal stem cell–derived exosomes on experimental type-1 autoimmune diabetes[J]. J Cell Biochem,2018,119(11):9433-9443. doi: 10.1002/jcb.27260
[6]	Lal C V,Olave N,Travers C,et al. Exosomal microRNA predicts and protects against severe bronchopulmonary dysplasia in extremely premature infants[J]. JCI Insight,2018,3(5):116-119.
[7]	An M,Zhu J,Wu J,et al. Circulating exosomes from pancreatic Cancer Accelerate the migration and proliferation of PANC-1 cells[J]. J Proteome Res,2018,17(4):1690-1699.
[8]	Rao P S S,O’Connell K,Finnerty T K. Potential role of extracellular vesicles in the pathophysiology of drug addiction[J]. Mol Neurobiol,2018,55(8):6909-6913.
[9]	Fan Q,Yang L,Zhang X,et al. The emerging role d exosome-derived non-coding RNAs in cancer biology[J]. Cancer Letter,2018,414:107-115. doi: 10.1016/j.canlet.2017.10.040
[10]	Fu X,Liu M,Qu S,et al. Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/AKt pathway[J]. J Exp Clin Cancer Res,2018,37:52. doi: 10.1186/s13046-018-0677-7
[11]	Ye L,Zhang Q,Cheng Y,et al. Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1+ regulatory B cell expansion[J]. Immunother Cancer,2018,6:145. doi: 10.1186/s40425-018-0451-6
[12]	Rao Q,Zou B,Lu Z,et al. Tumor-derived exosomes elicit tumor suppression in murine hepatocellular carcinoma models and humans in vitro[J]. Hepatology,2016,64:456-472. doi: 10.1002/hep.28549
[13]	Lin X J,Fang J H,Yang X J,et al. Hepatocellular carcinoma cell-secreted exosomal microRNA-210 promotes angiogenesis invitro and invivo[J]. Mol Ther Nucleic Acids,2018,11(6):243-252.
[14]	Chen L,Han Y,Li Y J,et al. Hepatocyte-derived exosomal MiR-194 activates PMVECs and promotes angiogenesis in hepatopulmonary syndrome[J]. Cell Death and Disease,2019,10:853. doi: 10.1038/s41419-019-2087-y
[15]	Yusuke Matsuura,Hiroshi Wada,Hidetoshi Eguchi,et al. Exosomal miR-155 Derived from Hepatocellular Carcinoma Cells Under Hypoxia Promotes Angiogenesis in Endothelial Cells[J]. Digestive Diseases and Sciences,2019,64(3):792-802.
[16]	Cao L Q,Yang X W,Chen Y B,et al. Exosomal miR-21 regulates the TETs/ PTENp1/PTEN pathway to promote hepatocellular carcinoma growth[J]. Molecular Cancer,2019,18:148. doi: 10.1186/s12943-019-1075-2
[17]	Yi P S,Li J S. High expression of miR-21 is not a predictor of poor prognosis in all patients with hepatocellular carcinoma[J]. Mol Clin Oncol,2018,8(6):733-739.
[18]	Hung J H,Li C H,Yeh C H,et al. MicroRNA-224 down-regulates Glycine N-methyltransferase gene expression in Hepatocellular Carcinoma[J]. Sci Rep,2018,8:12284. doi: 10.1038/s41598-018-30682-5
[19]	Tang J,Li Y,Liu K,et al. Exosomal miR-9-3p suppresses HBGF-5 expression and is a functional biomarker in hepatocellular carcinoma[J]. Minerva Med,2018,109(1):15-23.
[20]	Li B,Mao R,Liu C,et al. LncRNA FAL1 promotes cell proliferation and migration by acting as a CeRNA of miR-1236 in hepatocellular carcinoma cells[J]. Life Sci,2018,197:122-129. doi: 10.1016/j.lfs.2018.02.006
[21]	Fang T,Lv H,Lv G,et al. Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer[J]. Nat Commun,2018,9(1):191.
[22]	Ulrich H Weidle,Daniela Schmid,Fabian Birzele,et al. MicroRNAs Involved in Metastasis of Hepatocellular Carcinoma:Target Candidates,Functionality and E fficacy in Animal Models and Prognostic Relevance[J]. Cancer Genomics & Proteomics,2020,17:1-21.
[23]	Chu Y,Fan W,Guo W,et al. miR-1247-5p functions as a tumor suppressor in human hepatocellular carcinoma by targeting Wnt3[J]. Oncol Rep,2017,38:343-351. doi: 10.3892/or.2017.5702
[24]	Li D P,Fan J,Wu Y J,et al. MiR-155 up-regulated by TGF-β promotes epithelial-mesenchymal transition,invasion and metastasis of human hepatocellular carcinoma cells in vitro[J]. Am J Transl Res,2017,9(6):2956-2965.
[25]	Fu X,Wen H Q,Jing L,et al. MicroRNA‐155‐5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway[J]. Cancer Sci,2017,108(4):620-631. doi: 10.1111/cas.13177
[26]	Lian J,Jing Y,Dong Q,et al. miR - 192,a prognostic indicator,targets the SLC39A6/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinoma[J]. Oncotarget,2016,7:2672-2683. doi: 10.18632/oncotarget.6603
[27]	Fang J H,Zhang Z J,Shang L R,et al. Hepatomacell-secreted exosomal microRNA-103 increases vascular permeability and promotes metastasis by targeting junction proteins[J]. Hepatology,2018,68(4):1459-1475. doi: 10.1002/hep.29920
[28]	Liu J,Fan L,Yu H,et al. Endoplasmic Reticulum Stress Promotes Liver Cancer Cells to Release Exosomal miR-23a-3p and Upregulate PD-L1 Expression in Macrophages[J]. Hepatology,2019,70(1):241-258.
[29]	Wang X,Liu S S,Cao L,et al. miR-29a-3p suppresses cell proliferation and migration by downregulating IGF1R in hepatocellular carcinoma[J]. Oncotarget,2017,8(49):86592-86603. doi: 10.18632/oncotarget.21246
[30]	Ye W K,Li J K,Fang G,et al. Expression of microRNA 638 and sex-determining region Y-box 2 in hepatocellular carcinoma:Association between clinicopathological features and prognosis[J]. Oncol Lett,2018,15(5):7255-7264.
[31]	Shi M,Jiang Y,Yang L,et al. Decreased levels of serum exosomal miR-638 predict poor prognosis in hepatocellular carcinoma[J]. J Cell Biochem,2018,119(6):4711-4716.
[32]	Cheng J W,Chen Y K,Zhao P,et al. Dysregulation of miR-638 in hepatocellular carcinoma and its clinical significance[J]. Oncol Lett,2017,13(5):3859-3865. doi: 10.3892/ol.2017.5882
[33]	Huang Y H,Liang K H,Chien R N,et al. A circulating microRNA signature capable of assessing the risk of hepato-cellular carcinoma in cirrhotic patients[J]. Sci Rep,2017,7:523. doi: 10.1038/s41598-017-00631-9
[34]	Sun W,Luo J D,Jiang H,et al. Tumor exosomes:a double-edged sword in cancer therapy[J]. Acta Pharmacol Sin,2018,39(4):534-541. doi: 10.1038/aps.2018.17
[35]	Ebrahimkhani S,Vafaee F,Young P E,et al. Exosomal microRNA signatures in multiple sclerosis reflect disease status[J]. Sci Rep,2017,7:14293. doi: 10.1038/s41598-017-14301-3

Relative Articles(20)

Relative Articles

[1]	Lei ZHU, Ruixue LI, Changlei BAO, Chenchen HUANG, Shuxin LIANG, Zhenlin ZHAO, Hong ZHU. Effect of MSC-exo，a New Cell Delivery Tool，on Gene Delivery and Proliferation of Pancreatic Cancer. Journal of Kunming Medical University, 2024, 45(2): 39-48. doi: 10.12259/j.issn.2095-610X.S20240206
[2]	Hang CHEN, Qi CUI, Minshan HUANG, Jianjun LIU, Lanqing MA. Research Progress of miRNA in Non-alcoholic Fatty Liver Disease. Journal of Kunming Medical University, 2024, 45(1): 1-7. doi: 10.12259/j.issn.2095-610X.S20240101
[3]	Yixuan CHEN, Lin WANG, Xiuhong XIA, Zaikun PENG, Yi DING, Runjiao SHI, Xuefen LEI. Research Progress on the Mechanisms of Autophagy in Hepatocellular Carcinoma. Journal of Kunming Medical University, 2023, 44(4): 159-164. doi: 10.12259/j.issn.2095-610X.S20230416
[4]	Ming ZHANG, Chenglong YU, Jinpeng CAO. ZNF384 Regulates Metastasis of Hepatocellular Carcinoma via GCLM. Journal of Kunming Medical University, 2023, 44(11): 56-62. doi: 10.12259/j.issn.2095-610X.S20231108
[5]	Shijie CAO, Hongwei AN. Mechanism and Progress of MSC Derived Extracellular Vesicles in the Treatment of Ischemic Stroke. Journal of Kunming Medical University, 2023, 44(9): 155-160. doi: 10.12259/j.issn.2095-610X.S20230913
[6]	Liang ZHANG, Baoquan WANG, Xifeng LEI, Xu WANG, Yang KE, Wei ZHANG. M2 Macrophage-derived Exosome miR-1246 Regulates the Growth and Invasion of Gastric Cancer Cells. Journal of Kunming Medical University, 2023, 44(7): 69-77. doi: 10.12259/j.issn.2095-610X.S20230724
[7]	Haiyan FU, Junfang YAN, Hongjuan LI, Lin WANG, Jie ZHANG, Yujun ZHOU, Bin XU, Yu LUO. Effect of Time Interval on the Outcome with Transarterial Chemoembolization Followed Microwave Ablation with Hepatocellular Carcinoma. Journal of Kunming Medical University, 2022, 43(11): 63-70. doi: 10.12259/j.issn.2095-610X.S20221127
[8]	Jun GU, Zexi HE, Ting LUAN, Haifeng WANG, Jiansong WANG, Mingxia DING. Research Progress of Exosomes-derived Long Non-coding RNA in Bladder Cancer. Journal of Kunming Medical University, 2022, 43(1): 150-156. doi: 10.12259/j.issn.2095-610X.S20220110
[9]	Fan CAO, Yang-wen LIU, Lei WEI, Nan XIE, Yi-jian YANG, Cheng QIAN, Chun-mang LI, Bi-mang FU, Jiang-pin XU, Rong-ji YAN, Wang ZENG. Correlation between Hepatitis B Virus and Microvascular Invasion in Hepatocellular Carcinoma. Journal of Kunming Medical University, 2021, 42(3): 127-134. doi: 10.12259/j.issn.2095-610X.S20210331
[10]	Li-ya MA, Nan-quan RAO, He-feng YANG. Research Progress of Mesenchymal Stem Cell Exosomes in Oral Tissue Regeneration. Journal of Kunming Medical University, 2021, 42(5): 147-153. doi: 10.12259/j.issn.2095-610X.S20210527
[11]	Xiao CAI, Xue-tao YI, Jing-qing YAO, Xin-yu DAI, Zhong-quan TANG, Ting OU, Xiao-min ZHAO, Yun-tao LI. The Regulation of Exosome Derived from Human Bone Marrow Mesenchymal Stem Cells on the Polarization of Glioma-associated Macrophages. Journal of Kunming Medical University, 2021, 42(1): 38-45. doi: 10.12259/j.issn.2095-610X.S20210101
[12]	Jia YANG, Ya-xian LI, Ying-ying WANG, Lin XIAO, Chuan-yin LI, Fang TAN, Qian-li MA, Shu-yuan LIU. Association of the miR-149,miR-219 and miR-let-7 Polymorphisms with the Occurrence and Development of Non-small Cell Lung Cancer in a Chinese Han Population in Yunnan Province. Journal of Kunming Medical University, 2021, 42(10): 22-28. doi: 10.12259/j.issn.2095-610X.S20211037
[13]	Wei Han Xiao , Zhang Ai Jun , Li Qiang , Jin Pei Sheng . . Journal of Kunming Medical University, 2020, 41(09): 50-55.
[14]	Jia Feng Mei , Yin Shun Hui , Ran Li Quan , Tian Ming Tong , Zhang Ming Zhu . . Journal of Kunming Medical University, 2019, 40(10): 15-20.
[15]	Tan Hua , Ren Hong , Zhao Ling , You Ding Yun , Yang Ya Chen . Prognostic Factors of Patients with Primary Hepatocellular Carcinoma Treated with TACE. Journal of Kunming Medical University, 2019, 40(03): 29-34.
[16]	Yu Xiao Dong , Long Jiang . . Journal of Kunming Medical University, 2019, 40(09): 68-71.
[17]	Lei Xi Feng , Hou Feng Qiang , Liu Tao , Zhang Wei . . Journal of Kunming Medical University, 2018, 39(11): 11-15.
[18]	Lei Xi Feng , Hou Feng Qiang , Yang Shao Hua , Zhang Wei . . Journal of Kunming Medical University, 2018, 39(12): 49-53.
[19]	Chang Guo Ji , Gu Jin Song , Sun Lin . . Journal of Kunming Medical University, 2017, 38(05): 138-143.
[20]	Qiu Jian Wu . . Journal of Kunming Medical University,